Former OpenAI science lead raises $215m to automate drug discovery labs
TechCrunch - 22-Oct-2026Warp Sciences trains its lab robots by filming chemists at work
Previously the Live Forever Club — same community, now with a sharper mission for life extension
It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Warp Sciences trains its lab robots by filming chemists at work
AI in medical research meets the bench as Anthropic confirms a wet lab
Laboratory automation and mini organs aim to cut animal testing in Liverpool
Millions of lab-grown human tissues will train a new AI model of biology
Click on resource name for more details.
Biotechnology company combining experimental biology and automation with artificial intelligence
Optispan podcast episode - Dr. Ben Blue explores the cutting edge of longevity research
Multinational healthcare company that operates under Pharmaceuticals and Diagnostics divisions all over the world
Podcast from Beyond Biotech- LabGenius: Cutting through AI hype in drug development
Global biotech company providing robotic automation solutions to the life sciences industry
Reducing the time and cost of clinical tests will help us beat the big killers, then guide our personalised rejuvenation programmes